ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $433,924 | +23.3% | 79,619 | +51.8% | 0.00% | – |
Q2 2023 | $351,986 | -90.7% | 52,457 | -87.7% | 0.00% | -100.0% |
Q1 2023 | $3,778,921 | +34.1% | 427,964 | +16.0% | 0.00% | 0.0% |
Q4 2022 | $2,818,000 | -68.7% | 368,900 | -43.1% | 0.00% | -66.7% |
Q1 2022 | $9,000,000 | -44.7% | 648,479 | +11.8% | 0.00% | -40.0% |
Q4 2021 | $16,283,000 | -17.5% | 580,274 | -0.0% | 0.01% | -16.7% |
Q3 2021 | $19,729,000 | -9.4% | 580,500 | +8.9% | 0.01% | -14.3% |
Q2 2021 | $21,782,000 | -36.6% | 533,082 | -37.5% | 0.01% | -36.4% |
Q1 2021 | $34,343,000 | -23.1% | 853,032 | +12.9% | 0.01% | -31.2% |
Q4 2020 | $44,676,000 | +55.3% | 755,542 | +27.8% | 0.02% | +33.3% |
Q3 2020 | $28,760,000 | +72.3% | 591,408 | +71.4% | 0.01% | +71.4% |
Q2 2020 | $16,696,000 | +80.6% | 345,116 | +3.7% | 0.01% | +40.0% |
Q1 2020 | $9,243,000 | +7.7% | 332,671 | +16.0% | 0.01% | +25.0% |
Q4 2019 | $8,582,000 | +9.9% | 286,858 | +13.6% | 0.00% | +33.3% |
Q3 2019 | $7,806,000 | +0.6% | 252,602 | +57.3% | 0.00% | 0.0% |
Q2 2019 | $7,756,000 | – | 160,597 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |